Načítá se...
Nodal Involvement: Positive about the Role of the Recurrence Score in Estrogen Driven Breast Cancer?
It remains unclear whether there is clinical utility for withholding chemotherapy in HR+/HER2-, node-positive breast cancer based upon the 21-gene Recurrence Score. While we await the results from randomized, phase III trials, this editorial addresses additional observational data that suggest there...
Uloženo v:
| Vydáno v: | Cancer |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329661/ https://ncbi.nlm.nih.gov/pubmed/30387877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31814 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|